Jeff is a corporate attorney who advises life science companies executing M&A, financing, joint venture, licensing and commercial transactions.
He serves as outside general counsel to life science companies and navigates highly regulated environments and negotiates effective strategic and commercial relationships to help clients develop, commercialize and sell their products.
Jeff co-chairs the firm’s Life Sciences Group. He chairs the Board of Directors of the Minneapolis Heart Institute Foundation and serves on the Boards of Pillsbury United Communities and the South Dakota Biotech Association.
Before joining Fredrikson & Byron, Jeff founded and led a consulting firm that provided general counsel services to life science companies, including serving as the General Counsel of Vios Medical, Inc., an emerging growth healthcare information technology company with an IoT-based patient management platform, prior to its sale to Murata Manufacturing Company. Previously, Jeff was the Vice President and Deputy General Counsel of SUPERVALU, INC. where he led the M&A, securities, financing and real estate legal teams. Jeff developed substantial medical technology expertise during his time at Medtronic as an M&A lawyer, corporate development leader and divisional counsel and has a strong background in healthcare law. Earlier in his career, Jeff was a corporate and restructuring attorney at Skadden, Arps, Slate Meagher & Flom.
